Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Summary of Consolidated Financial Results for the 3rd Quarter of Fiscal Year
Ending March 31, 2025(J-GAAP)
February 3, 2025 | |||
Company name: T.RAD Co., Ltd. | Listing: Tokyo Stock Exchange, Prime Market | ||
Code No.: | 7236 | URL: | http://www.trad.co.jp |
Representative: Tomio Miyazaki, President & CEO & COO | |||
Contact: | Kaoru Kinoshita, Managing Executive Officer, | Tel: | +81-3-3373-1101 |
In charge of Finance & Accounting | |||
Scheduled date of start of dividend payments: | ― | ||
Supplemental materials prepared for consolidated financial results: None | |||
Briefing on consolidated financial results: None |
(Amounts less than one million yen have been truncated)
1. Consolidated Financial Performance for the 3rd Quarter of Fiscal Year Ending March 31, 2025 (April 1, 2024 to December 31, 2024)
(1) Consolidated operating performance | (Percentage figures indicate year-on-year change) | |||||||||||||||||
Net sales | Operating income | Ordinary income | Profit attributable to | |||||||||||||||
owners of parent | ||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |||||||||||
Nine months ended | 113,844 | -6.8 | 3,105 | -1.7 | 4,117 | 16.6 | 1,156 | -14.5 | ||||||||||
December31, 2024 | ||||||||||||||||||
Nine months ended | 122,135 | 5.0 | 3,159 | 368.0 | 3,532 | 138.0 | 1,352 | ― | ||||||||||
December31, 2023 | ||||||||||||||||||
Note: Comprehensive income | ||||||||||||||||||
Nine months ended December 31, 2024: ¥ | 1,394 million (-62.4%) | |||||||||||||||||
Nine months ended December 31, 2023: ¥ | 3,713 million (-9.6%) | |||||||||||||||||
Net income per share | Diluted net income per share | |||||||||||||||||
Yen | Yen | |||||||||||||||||
Nine months ended | 176.96 | ― | ||||||||||||||||
December31, 2024 | ||||||||||||||||||
Nine months ended | 207.04 | ― | ||||||||||||||||
December31, 2023 | ||||||||||||||||||
(2) Consolidated financial position | ||||||||||||||||||
Total assets | Net assets | Equity ratio | Net assets per share | |||||||||||||||
Millions of yen | Millions of yen | % | Yen | |||||||||||||||
Nine months ended | 95,541 | 44,747 | 46.8 | 6,910.48 | ||||||||||||||
December31, 2024 | ||||||||||||||||||
Fiscal year ended | 103,087 | 45,286 | 43.5 | 6,860.31 | ||||||||||||||
March 31, 2024 | ||||||||||||||||||
Reference: Shareholders' equity | ||||||||||||||||||
As of December 31, 2024: ¥44,700 million | ||||||||||||||||||
As of March 31, 2024 : ¥44,890 million | ||||||||||||||||||
2. Dividends | ||||||||||||||||||
Dividends per Share | ||||||||||||||||||
1Q | 2Q | 3Q | Year-end | Total | ||||||||||||||
Yen | Yen | Yen | Yen | Yen | ||||||||||||||
Fiscal year ended | ― | 80.00 | ― | 100.00 | 180.00 | |||||||||||||
March 31, 2024 | ||||||||||||||||||
Fiscal year ending | ― | 90.00 | ― | |||||||||||||||
March 31, 2025 | ||||||||||||||||||
Fiscal year ending | ||||||||||||||||||
March 31, 2025 | 90.00 | 180.00 | ||||||||||||||||
(Forecast) | ||||||||||||||||||
Note: Revisions to dividend forecasts since the latest official announcement: No | ||||||||||||||||||
1 |
3. Forecast of Consolidated Financial Performance for the Fiscal Year Ending March 31, 2025 (April 1, 2024 to March 31, 2025)
(Percentage figures indicate changes from the same period of the previous year)
Profit attributable to | Net | ||||||||
Net sales | Operating income | Ordinary income | income per | ||||||
owners of parent | |||||||||
share | |||||||||
Millions of | % | Millions of | % | Millions of | % | Millions of | % | Yen | |
yen | yen | yen | yen | ||||||
Fiscal year ending | 159,000 | 0.2 | 4,000 | -8.0 | 4,500 | -15.7 | 1,500 | 20.5 | 229.24 |
March 31, 2025 | |||||||||
Note: Revisions to the forecast of consolidated financial performance since the latest official announcement: No |
4. Other
-
Changes in significant subsidiaries during the current quarter
(changes in specific subsidiaries resulting in changes in the scope of consolidation): No - Adoption of specific accounting policies for quarterly consolidated financial statements: None
- Changes in accounting principles, estimation procedures or presentation methods
- Changes associated with revision of accounting standards: Yes
- Changes other than 1): None
- Changes accounting estimation procedures: None
- Changes in presentation methods: None
- Number of shares issued and outstanding (common stock)
-
Number of shares issued and outstanding at end of period (including treasury stock) As of December 31, 2024: 6,592,411 shares
As of March 31, 2024: 6,592,411 shares - Number of shares of treasury stock at end of period As of December 31, 2024: 123,862 shares
As of March 31, 2024: 48,944 shares - Average number of shares outstanding during the period Nine months ended December 31, 2024: 6,536,256 shares Nine months ended December 31, 2023: 6,533,320 shares
-
Number of shares issued and outstanding at end of period (including treasury stock) As of December 31, 2024: 6,592,411 shares
- Review by certified public accountant or audit firm of the attached quarterly consolidated financial statements: None
- Explanations for proper use of forecasts and other specific affairs
The forward-looking statement such as forecast of financial performance etc. described in this report based on information currently available and certain assumptions judged to be reasonable. Actual performance may differ significantly from these projections due to various factors.
2
Quarterly Consolidated Financial Statements and main notes
(1) Quarterly consolidated balance sheets
(Millions of yen) | ||
FY2023 | FY2024_3Q | |
As of March 31, 2024 | As of December 31, | |
2024 | ||
Amount | Amount | |
(Assets) | ||
Current assets | ||
Cash and deposits | 20,332 | 15,620 |
Notes receivable-trade | 1,080 | 632 |
Electronically recorded monetary claims-operating | 3,191 | 2,374 |
Accounts receivable-trade | 25,587 | 24,893 |
Short-term investment securities | 299 | - |
Merchandise and finished goods | 3,572 | 3,499 |
Work in process | 991 | 959 |
Raw materials and supplies | 8,985 | 8,836 |
Others | 2,703 | 2,916 |
Allowance for doubtful accounts | (127) | (481) |
Total current assets | 66,617 | 59,252 |
Noncurrent assets | ||
Tangible fixed assets | ||
Building and structures, net | 6,175 | 6,058 |
Machinery, equipment and vehicles, net | 12,694 | 12,399 |
Land | 2,509 | 2,529 |
Lease assets, net | 1,422 | 1,250 |
Construction in progress | 3,650 | 4,175 |
Other tangible fixed assets, net | 1,682 | 1,919 |
Total tangible fixed assets | 28,135 | 28,332 |
Intangible assets | ||
Others | 3,125 | 1,917 |
Total intangible assets | 3,125 | 1,917 |
Investments and other assets | ||
Investment securities | 1,998 | 2,826 |
Net defined benefit asset | 2,431 | 2,481 |
Deferred tax assets | 226 | 227 |
Others | 558 | 502 |
Allowance for doubtful accounts | (5) | - |
Total investments and other assets | 5,210 | 6,038 |
Total noncurrent assets | 36,470 | 36,288 |
Total assets | 103,087 | 95,541 |
3
(Millions of yen) | ||
FY2023 | FY2024_3Q | |
As of March 31, 2024 | As of December 31, | |
2024 | ||
Amount | Amount | |
(Liabilities) | ||
Current liabilities | ||
Notes and accounts payable-trade | 15,685 | 12,899 |
Electronically recorded obligations - operating | 5,917 | 6,470 |
Short-term loans payable | 7,531 | 6,674 |
Lease obligations | 447 | 443 |
Income taxes payable | 1,089 | 387 |
Accrued expenses | 3,793 | 3,840 |
Provision for bonuses | 1,667 | 1,024 |
Provision for directors' bonuses | 32 | 22 |
Provision for product warranties | 787 | 1,902 |
Provision for loss on order received | 228 | 227 |
Electronically recorded obligations - non-operating | 482 | 572 |
Others | 1,380 | 1,193 |
Total current liabilities | 39,043 | 35,660 |
Noncurrent liabilities | ||
Long-term loans payable | 14,340 | 11,090 |
Lease obligations | 2,596 | 2,292 |
Deferred tax liabilities | 1,315 | 1,149 |
Net defined benefit liability | 294 | 333 |
Provision for share awards | 44 | 128 |
Asset retirement obligations | 93 | 94 |
Others | 73 | 44 |
Total noncurrent liabilities | 18,758 | 15,132 |
Total liabilities | 57,801 | 50,793 |
(Net assets) | ||
Shareholders' equity | ||
Capital stock | 8,570 | 8,570 |
Capital surplus | 6,911 | 6,864 |
Retained earnings | 22,510 | 22,418 |
Treasury stock | (114) | (395) |
Total shareholders' equity | 37,877 | 37,458 |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities | 19 | 20 |
Foreign currency translation adjustment | 5,012 | 5,408 |
Remeasurements of defined benefit plans | 1,980 | 1,813 |
Total accumulated other comprehensive income | 7,012 | 7,242 |
Non-controlling interests | 396 | 47 |
Total net assets | 45,286 | 44,747 |
Total liabilities and net assets | 103,087 | 95,541 |
4
- Quarterly consolidated statements of income and quarterly consolidated statement of comprehensive income (Quarterly consolidated statements of income)
(Millions of yen) | ||
Nine months ended | Nine months ended | |
December 31, 2023 | December 31, 2024 | |
(Apr. 1, 2023-December 31, 2023) | (Apr. 1, 2024-December 31, 2024) | |
Amount | Amount | |
Net sales | 122,135 | 113,844 |
Cost of sales | 111,205 | 100,506 |
Gross profit | 10,929 | 13,338 |
Selling, general and administrative expenses | ||
Packing and delivery expenses | 1,184 | 1,296 |
Salaries and allowances | 1,961 | 1,971 |
Provision for bonuses | 255 | 299 |
Provision for directors' bonuses | 34 | 22 |
Retirement benefit expenses | 25 | (20) |
Welfare expenses | 1,127 | 1,136 |
Provision for product warranties | 203 | 1,584 |
Provision of allowance for doubtful accounts | 5 | 352 |
Research and development expenses | 898 | 1,262 |
Provision for share awards | 11 | 84 |
Others | 2,061 | 2,242 |
Total selling, general and administrative expenses | 7,769 | 10,233 |
Operating income (loss) | 3,159 | 3,105 |
Non-operating income | ||
Interest income | 175 | 213 |
Dividends income | 3 | 3 |
Equity in earnings of affiliates | 400 | 352 |
Foreign exchange gains | 144 | 459 |
Others | 176 | 283 |
Total non-operating income | 901 | 1,313 |
Non-operating expenses | ||
Interest expenses | 518 | 298 |
Others | 9 | 2 |
Total non-operating expenses | 528 | 301 |
Ordinary income (loss) | 3,532 | 4,117 |
5
(Millions of yen) | ||
Nine months ended | Nine months ended | |
December 31, 2023 | December 31, 2024 | |
(Apr. 1, 2023-December 31, 2023) | (Apr. 1, 2024-December 31, 2024) | |
Amount | Amount | |
Extraordinary income | ||
Gain on sales of noncurrent assets | 81 | 13 |
Gain on sales of investment securities | 199 | - |
Total extraordinary income | 280 | 13 |
Extraordinary loss | ||
Loss on sales of noncurrent assets | 10 | 9 |
Loss on retirement of noncurrent assets | 69 | 1,161 |
Loss on sale of shares of subsidiaries and associates | 80 | - |
Impairment loss | - | 199 |
Total extraordinary loss | 160 | 1,371 |
Income (loss) before income taxes | 3,652 | 2,759 |
Income taxes-current | 2,040 | 1,650 |
Income taxes-deferred | 231 | (55) |
Total income taxes | 2,271 | 1,594 |
Profit (loss) | 1,380 | 1,164 |
Profit (loss) attributable to non-controlling interests | 28 | 8 |
Profit (loss) attributable to owners of parent | 1,352 | 1,156 |
6
(Quarterly consolidated statement of comprehensive income)
(Millions of yen) | |||
Nine months ended | Nine months ended | ||
December 31, 2023 | December 31, 2024 | ||
(Apr. 1, 2023-December 31, 2023) | (Apr. 1, 2024-December 31, 2024) | ||
Amount | Amount | ||
Profit (loss) | 1,380 | 1,164 | |
Other comprehensive income | |||
Valuation difference on available-for-sale securities | 5 | 0 | |
Foreign currency translation adjustment | 2,216 | 326 | |
Remeasurements of defined benefit plans, net of tax | (51) | (166) | |
Share of other comprehensive income of associates accounted for using equity | 162 | 68 | |
method | |||
Total other comprehensive income | |||
2,332 | 229 | ||
Comprehensive income | 3,713 | 1,394 | |
(Breakdown) | |||
Comprehensive income attributable to owners of the parent | 3,555 | 1,386 | |
Comprehensive income attributable to non-controlling interests | 157 | 8 | |
7
(3) Quarterly consolidated statements of cash flows
(Millions of yen) | ||
Nine months ended | Nine months ended | |
December 31, 2023 | December 31, 2024 | |
(Apr. 1, 2023-December 31, 2023) | (Apr. 1, 2024-December 31, 2024) | |
Amount | Amount | |
Net cash provided by (used in) operating activities | ||
Profit (loss) before income taxes | 3,652 | 2,759 |
Depreciation and amortization | 4,643 | 3,985 |
Retirement benefit expenses | (75) | (236) |
Increase (decrease) in retirement benefit asset and liability | (5) | (25) |
Increase (decrease) in allowance for doubtful accounts | (120) | 346 |
Increase (decrease) in provision for bonuses | (502) | (643) |
Increase (decrease) in provision for directors' bonuses | 9 | (10) |
Increase (decrease) in provision for product warranties | (185) | 1,108 |
Loss on retirement of noncurrent assets | 69 | 1,161 |
Loss(gain) on sales of tangible fixed assets | (70) | (3) |
Loss (gain) on sales of investment securities | (119) | - |
Interest and dividends income | (179) | (217) |
Interest expenses | 518 | 298 |
Foreign exchange losses (gains) | (206) | (214) |
Equity in (earnings) losses of affiliates | (400) | (352) |
Impairment loss | - | 199 |
Decrease(increase) in notes and accounts receivable-trade | (1,964) | 2,266 |
Decrease(increase) in inventories | 3,797 | 428 |
Increase(decrease) in notes and accounts payable-trade | 2,358 | (2,520) |
Decrease(increase) in other current assets | 225 | (224) |
Increase (decrease) in other current liabilities | (703) | 124 |
Other, net | 43 | 74 |
Subtotal | 10,783 | 8,304 |
Interest and dividends income received | 1,892 | 400 |
Interest expenses paid | (506) | (314) |
Income taxes paid | (1,881) | (2,329) |
Net cash provided by (used in) operating activities | 10,288 | 6,061 |
8
(Millions of yen) | ||
Nine months ended | Nine months ended | |
December 31, 2023 | December 31, 2024 | |
(Apr. 1, 2023-December 31, 2023) | (Apr. 1, 2024-December 31, 2024) | |
Amount | Amount | |
Net cash provided by (used in) investing activities | ||
Purchase of tangible assets | (4,372) | (4,102) |
Proceeds from sales of tangible fixed assets | 119 | 10 |
Purchase of intangible assets | (764) | (250) |
Purchase of investment securities | - | (580) |
Proceeds from sales of investment securities | 202 | - |
Payments into time deposit | (1,626) | (2,232) |
Proceeds from withdrawal of time deposits | 1,152 | 1,289 |
Others | (151) | 132 |
Net cash provided by (used in) investing activities | (5,440) | (5,732) |
Net cash provided by (used in) financing activities | ||
Net increase (decrease) in short-term loans payable | (1,942) | (4,224) |
Proceeds from long-term loans payable | 3,210 | 650 |
Repayment of long-term loans payable | (2,237) | (610) |
Purchase of treasury stock | - | (280) |
Cash dividends paid | (525) | (1,248) |
Cash dividends paid to non-controlling shareholders | (246) | (100) |
Payments from changes in ownership interests in subsidiaries that do not | - | (381) |
result in change in scope of consolidation | ||
Others | (280) | (299) |
Net cash provided by (used in) financing activities | (2,022) | (6,495) |
Effect of exchange rate change on cash and cash equivalents | 836 | 212 |
Net increase (decrease) in cash and cash equivalents | 3,662 | (5,954) |
Cash and cash equivalents at beginning of period | 10,361 | 20,204 |
Cash and cash equivalents at end of period | 14,023 | 14,250 |
9
